Experimental Hematology and Oncology · 2024 · 13 citations · 33 references
Life SciencesImmunologyOncologyCancer ImmunologyInnate ImmunityTumor ImmunologyCancer ImmunotherapyImmune Checkpoint ModulationImmune Checkpoint RegulationMacrophage BiologyPhagocyte BiologyTumor-associated MacrophagesCancer-associated MacrophagesInnate Immunity PathwaysM1 Macrophage PhenotypesM2 Macrophage PhenotypesM2-like Macrophage ActivationMacrophage PolarizationMonocyte-derived MacrophagesPhagocytic Activity
Abstract Background VISTA is a well-known immune checkpoint in T cell biology, but its role in innate immunity is less established. Here, we investigated the role of VISTA on anticancer macrophage immunity, with a focus on phagocytosis, macrophage polarization and concomitant T cell activation. Methods Macrophages, differentiated from VISTA overexpressed THP-1 cells and cord blood CD34 + cell-derived monocytes, were used in phagocytosis assay using B lymphoma target cells opsonized with Rituximab. PBMC-derived macrophages were used to assess the correlation between phagocytosis and VISTA expression. qRT-PCR, flow cytometry, and enzyme-linked immunosorbent assay were performed to analyze the impact of VISTA on other checkpoints and M1/M2-like macrophage biology. Additionally, flow cytometry was used to assess the frequency of CD14 + monocytes expressing VISTA in PBMCs from 65 lymphoma patients and 37 healthy donors. Results Ectopic expression of VISTA in the monocytic model cell line THP-1 or in primary monocytes triggered differentiation towards the macrophage lineage, with a marked increase in M2-like macrophage-related gene expression and decrease in M1-like macrophage-related gene expression. VISTA expression in THP-1 and monocyte-derived macrophages strongly downregulated expression of SIRPα, a prominent ‘don’t eat me’ signal, and augmented phagocytic activity of macrophages against cancer cells. Intriguingly, expression of VISTA’s extracellular domain alone sufficed to trigger phagocytosis in ∼ 50% of cell lines, with those cell lines also directly binding to recombinant human VISTA, indicating ligand-dependent and -independent mechanisms. Endogenous VISTA expression was predominantly higher in M2-like macrophages compared to M0- or M1-like macrophages, with a positive correlation observed between VISTA expression in M2c macrophages and their phagocytic activity. VISTA-expressing macrophages demonstrated a unique cytokine profile, characterized by reduced IL-1β and elevated IL-10 secretion. Furthermore, VISTA interacted with MHC-I and downregulated its surface expression, leading to diminished T cell activation. Notably, VISTA surface expression was identified in monocytes from all lymphoma patients but was less prevalent in healthy donors. Conclusions Collectively, VISTA expression associates with and drives M2-like activation of macrophages with a high phagocytic capacity yet a decrease in antigen presentation capability to T cells. Therefore, VISTA is a negative immune checkpoint regulator in macrophage-mediated immune suppression.
33
The HDOCK server for integrated protein–protein docking
Yumeng Yan, Huanyu Tao, Jiahua He et al. · Nature Protocols · 2020 · 1.8K citations
HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy
Yumeng Yan, Di Zhang, Pei Zhou et al. · Nucleic Acids Research · 2017 · 1.4K citations · Full text
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Xiaojuan Liu, Yang Pu, Kyle R. Cron et al. · Nature Medicine · 2015 · 758 citations · Full text
Life Sciences, Immunology, Oncology +14